Evaluating Guanfacine Hydrochloride in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adult Patients: Design, Development and Place in Therapy
Authors:
Open Access
- 1 May 2021
- journal article
- review article
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 15, 1965-1969
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is characterized by age-inappropriate and impairing levels of inattention, hyperactivity, or impulsivity, or a combination of these characteristics. It is estimated to affect around 4% of adults worldwide. In the past few decades, prescriptions for ADHD drugs (psychostimulants and non-psychostimulants) have increased significantly. However, the efficacy and safety of adult ADHD medications remains controversial. Guanfacine extended-release (GXR) is a non-psychostimulant ADHD drug that is a selective α 2A-adrenergic receptor agonist, first approved for treatment of adult ADHD in Japan in June 2019. Our aim was to provide an overview of GXR pharmacology and review the studies on efficacy and safety that have been conducted in adults with ADHD. The beneficial actions of guanfacine are thought to be attributed to the strengthening of prefrontal cortical network connections, which regulate attention, emotion, and behavior via the activity at post-synaptic α 2A receptors. Current evidence of GXR efficacy and safety suggests that GXR is an effective monotherapy treatment option for adults with ADHD.Keywords
This publication has 24 references indexed in Scilit:
- Guanfacine ER for the treatment of adolescent attention-deficit/hyperactivity disorderExpert Opinion on Pharmacotherapy, 2012
- Trends of Outpatient Prescription Drug Utilization in US Children, 2002–2010Pediatrics, 2012
- ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and AdolescentsPediatrics, 2011
- European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHDBMC Psychiatry, 2010
- Meta-Analysis: Treatment of Attention-Deficit/Hyperactivity Disorder in Children With Comorbid Tic DisordersJournal of the American Academy of Child & Adolescent Psychiatry, 2009
- Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity DisorderJournal of the American Academy of Child & Adolescent Psychiatry, 2007
- Neurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical FunctionsBiological Psychiatry, 2005
- The Effects of an Alpha-2 Adrenergic Agonist, Guanfacine, on rCBF in Human Cortex in Normal Controls and Subjects with Focal EpilepsyNeuropsychopharmacology, 2000
- Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus MonkeyScience, 1979
- Pre- and postsynaptic effects of α-agonists inthe anococcygeus muscle of the pithed ratEuropean Journal of Pharmacology, 1979